BIO-TECHNE Corp

10-K & 10-Q Filings

Bio-Techne Corporation is a Minnesota-based company with global headquarters in Minneapolis. It was founded in 1976 and became a publicly traded company in 1985. The company develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. Bio-Techne operates in two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment offers specialized proteins, antibodies, small molecules, tissue culture sera, and cell selection technologies for research use and next-generation diagnostics and therapeutics. It also provides protein analysis instruments and immunoassays used in quantifying proteins in various biological fluids. The segment's products are used by researchers in academia and industry, diagnostic/companion diagnostic and therapeutic customers, and production and quality control departments at biotech and pharmaceutical companies. The Diagnostics and Genomics segment focuses primarily on the diagnostics market and includes spatial biology, liquid biopsy, molecular diagnostics kits and products, and diagnostics reagents. The segment's products are used by researchers in academia and pharmaceutical and biotech companies, as well as in clinical settings for diagnostics and research purposes. Bio-Techne's website is www.bio-techne.com, and its common stock is listed on the NASDAQ under the symbol "TECH."

12 mos ending Jun 30, 201212 mos ending Jun 30, 201312 mos ending Jun 30, 201412 mos ending Jun 30, 201512 mos ending Jun 30, 201612 mos ending Jun 30, 201712 mos ending Jun 30, 201812 mos ending Jun 30, 201912 mos ending Jun 30, 202012 mos ending Jun 30, 202112 mos ending Jun 30, 202212 mos ending Jun 30, 20239 mos ending Mar 31, 20239 mos ending Mar 31, 2024CAGR %YoY %Revenue (+)
$314.56
310.57
357.76
563.00
642.99
714.01
738.69
931.03
1105.60
1136.70
835.38
852.96
12.39%2.10%Cost of Revenue (-)
$78.76
79.47
106.35
188.46
210.85
240.51
255.50
298.18
349.10
366.89
270.26
286.58
15.01%6.04%Gross Profit (+)
$235.80
231.11
251.41
374.54
432.14
473.49
483.19
632.85
756.50
769.82
565.12
566.38
11.36%0.22%Selling, General & Administrative (-)
$41.68
43.38
60.72
200.44
240.64
264.36
260.58
324.95
372.77
378.38
291.62
332.84
22.20%14.13%Research & Development (-)
$27.91
29.26
30.95
53.51
55.33
62.41
65.19
70.60
87.14
92.49
69.07
72.67
11.51%5.21%Operating Expenses (-)
$69.59
72.64
91.66
253.96
295.96
326.77
325.77
395.55
459.91
470.87
360.70
405.51
18.98%12.42%Costs & Expenses (Total) (-)
$148.35
152.11
198.01
442.42
506.81
567.29
581.27
693.74
809.01
837.76
630.96
692.10
17.04%9.69%Operating Income/Loss (+)
$166.21
158.47
159.75
120.58
136.18
146.72
157.42
237.30
296.59
298.94
204.42
160.86
5.48%-21.31%Non-operating Income/Expense (+)
$-4.01
2.19
1.64
-8.62
-10.23
-34.70
119.06
-89.12
4.80
39.72
45.92
-16.84
-136.66%Interest Expense (-)
$
7.36
10.19
21.70
19.20
13.95
11.31
11.21
Earnings before Tax (+)
$162.19
160.66
161.39
111.96
125.95
112.02
276.48
148.18
301.39
338.66
250.34
144.03
6.92%-42.47%Tax Expense (-)
$49.86
48.10
50.44
35.88
-0.20
15.94
47.18
8.59
38.29
53.22
40.38
16.51
0.59%-59.12%Income/Loss (Continuing Operations) (+)
$112.33
112.56
110.95
76.09
126.15
96.07
229.30
139.59
263.10
285.44
209.96
127.52
8.85%-39.27%Profit/Loss (+)
$
139.59
263.10
285.44
209.96
127.52
-39.27%Net Income/Loss (NCI) (-)
$
-0.82
-8.95
0.18
0.18
Net Income/Loss (+)
$112.33
112.56
110.95
76.09
126.15
96.07
229.30
140.41
272.05
285.26
209.78
127.52
8.84%-39.21%Net Income/Loss (Common) (+)
$112.33
112.56
110.95
76.09
126.15
96.07
229.30
140.41
272.05
285.26
209.78
127.52
8.84%-39.21%EPS (Basic)
$3.04
3.06
3.01
2.04
3.36
2.54
6.00
3.62
6.93
1.81
1.34
0.81
-4.60%-39.55%EPS (Diluted)
$3.04
3.05
3.00
2.03
3.31
2.47
5.82
3.47
6.63
1.76
1.30
0.79
-4.85%-39.23%Weighted Avg Shares (Basic)
36.94
36.84
36.89
37.31
37.48
37.78
38.20
38.75
39.22
157.18
157.07
157.66
14.07%0.37%Weighted Avg Shares (Diluted)
37.01
36.90
37.01
37.50
38.05
38.89
39.40
40.48
41.03
161.85
161.77
160.82
14.36%-0.59%Cash
$116.67
163.79
318.57
54.53
64.24
91.61
121.99
100.89
146.63
199.09
172.57
180.57
127.28
139.91
4.05%9.93%Short-term Investments
$152.31
169.15
44.79
56.39
31.60
66.10
59.76
65.15
124.27
32.46
74.46
23.74
29.91
5.40
-15.55%-81.96%Receivables
$35.67
38.18
47.87
70.03
93.39
116.83
120.30
137.47
122.53
145.38
194.55
218.47
216.41
227.89
17.91%5.30%Inventory
$38.28
34.88
38.85
49.58
57.10
60.15
85.65
91.05
103.15
116.75
141.12
171.64
169.46
179.50
14.62%5.92%Prepaid Expenses (Current)
$1.50
1.53
2.59
Other Assets (Current)
$2.07
1.99
16.75
17.75
7.56
13.33
10.67
18.06
24.34
16.92
22.86
27.07
27.92
57.95
26.31%107.58%Assets (Current)
$346.51
409.52
469.41
248.28
253.89
348.02
398.37
412.61
520.92
510.61
605.56
621.48
571.00
610.65
5.45%6.94%Securities & Long-term Investments
$145.02
132.91
14.02
Property, Plant & Equipment (Net)
$93.79
108.76
117.12
129.75
132.36
135.12
145.35
154.04
248.29
281.74
288.80
324.53
321.55
340.99
11.95%6.05%Goodwill & Intangibles
$132.16
124.89
260.25
683.48
734.01
1031.07
1044.22
1312.10
1244.85
1459.03
1353.62
1407.38
1423.80
1497.39
23.99%5.17%Other Assets
$1.85
2.03
1.69
1.85
1.92
44.00
5.27
5.67
13.52
11.57
46.83
285.30
283.35
272.14
58.10%-3.96%Assets (Non-current)
$372.82
368.58
393.08
815.08
868.29
1210.19
1194.84
1471.80
1506.67
1752.35
1689.25
2017.21
2028.70
2110.52
16.59%4.03%Assets (Total)
$719.32
778.10
862.49
1063.36
1129.58
1558.22
1593.20
1884.41
2027.59
2262.96
2294.80
2638.69
2599.70
2721.17
12.54%4.67%Accounts Payable
$21.52
22.14
20.44
32.36
45.67
64.45
72.44
77.00
65.65
101.30
126.94
89.33
99.45
103.10
13.82%3.67%Debt (Current)
$
12.50
12.50
12.50
12.50
Other Liabilities (Current)
$14.23
9.94
5.95
7.40
8.48
71.07
7.07
12.48
28.52
38.49
36.58
39.18
41.72
46.72
9.64%12.00%Liabilities (Current)
$35.75
32.08
26.39
39.77
54.15
135.52
79.51
101.98
106.67
152.28
176.02
128.51
141.16
149.82
12.33%6.13%Debt (Non-current)
$
73.00
91.50
343.77
339.00
492.66
344.24
328.83
243.41
350.00
370.00
389.00
5.14%Other Liabilities
$9.13
8.47
33.84
103.66
104.65
129.30
95.63
124.18
195.49
210.61
174.37
193.67
198.85
167.97
32.00%-15.53%Liabilities (Non-current)
$9.13
8.47
33.84
176.66
196.15
473.07
434.63
616.84
539.73
539.44
417.78
543.67
568.85
556.98
44.99%-2.09%Liabilities (Total)
$44.88
40.56
60.23
216.42
250.30
608.59
514.14
718.82
646.40
691.72
593.79
672.18
710.01
706.79
27.90%-0.45%Retained Earnings
$520.45
587.73
653.28
713.85
770.55
799.03
876.93
931.93
1057.47
1085.46
1122.92
1309.46
1246.61
1297.69
8.75%4.10%AOCI
$21.77
14.55
-5.39
-30.59
-70.41
-48.94
-44.81
-83.52
-97.20
-57.29
-75.20
-66.06
-73.55
-75.31
-2.39%Shareholder's Equity
$674.44
737.54
795.26
846.93
879.28
949.63
1079.06
1165.59
1381.19
1571.23
1701.01
1966.52
1889.69
2014.38
10.22%6.60%Liabilities & Equity
$719.32
778.10
862.49
1063.36
1129.58
1558.22
1593.20
1884.41
2027.59
2262.96
2294.80
2638.69
2599.70
2721.17
12.54%4.67%Net Income/Loss
$112.33
112.56
110.95
107.73
104.48
76.09
126.15
96.07
229.30
139.59
263.10
285.44
209.96
127.52
8.85%-39.27%Depreciation & Amortization
$12.47
12.32
19.18
37.23
42.76
60.04
64.46
78.17
82.74
87.75
101.07
107.24
80.31
83.65
21.61%4.16%Increase/Decrease in Working Capital
$3.94
5.27
1.84
11.37
15.04
13.93
-1.90
27.75
5.25
-29.26
69.52
90.58
79.71
-0.13
32.98%-100.16%Share-based Compensation
$1.64
1.86
3.52
5.96
9.43
14.63
28.24
32.28
32.37
48.98
42.18
39.23
41.31
30.98
33.45%-25.02%Adjustments to Reconcile Net Income
$14.41
11.00
25.81
31.62
39.39
67.88
44.22
85.55
-24.08
212.58
62.17
-31.05
-38.96
95.97
346.34%Net Cash (Operating)
$126.75
123.56
136.76
139.36
143.87
143.45
170.37
181.62
205.22
352.16
325.27
254.39
171.00
223.49
6.54%30.69%Capital Expenditure
$6.02
22.45
133.00
440.01
108.32
308.96
88.78
314.90
51.74
269.65
44.91
353.60
342.77
214.60
44.82%-37.39%Net Cash (Investing)
$-21.67
-31.20
49.69
-426.49
-107.57
-305.95
-38.71
-336.80
27.09
-243.52
-96.85
-265.65
-260.89
-194.22
25.55%Increase/Decrease in Debt
$
68.04
18.50
252.00
-4.50
166.50
-148.50
-15.50
-85.50
94.00
114.00
39.00
-65.79%Increase/Decrease in Equity
$-23.60
-1.82
5.26
19.17
22.55
20.87
21.91
-83.79
10.25
1.84
-42.04
-2388.57%Interest Expenses
$
5.77
12.39
114.67%Dividends Paid
$41.02
43.46
45.39
47.11
47.61
47.33
47.97
48.36
48.90
49.62
50.19
50.28
37.69
37.79
1.87%0.28%Net Cash (Financing)
$-64.63
-44.68
-36.81
31.28
-23.08
189.39
-99.19
134.38
-183.80
-62.55
-242.85
22.62
46.84
-62.30
-233.02%Cash Taxes Paid
$
62.58
44.85
-28.34%Effect of Exchange Rate
$-1.39
-0.57
5.14
-8.18
-3.51
0.49
-2.09
-0.31
-2.77
6.37
-12.09
-3.36
-2.23
-7.62
-241.52%Increase/Decrease in Cash
$39.06
47.11
154.78
-264.04
9.71
27.38
30.38
-21.10
45.74
52.47
-26.52
8.00
-45.28
-40.66
-13.42%10.22%Cash (Beginning)
$77.61
116.67
163.79
318.57
54.53
64.24
91.61
121.99
100.89
146.63
199.09
172.57
172.57
180.57
7.53%4.64%Cash (Ending)
$116.67
163.79
318.57
54.53
64.24
91.61
121.99
100.89
146.63
199.09
172.57
180.57
127.28
139.91
4.05%9.93%NOPAT
$115.11
111.02
109.82
81.95
136.39
125.84
130.56
223.54
258.91
251.97
153.32
110.78
7.38%-27.75%Gross Margin %
74.96%
74.41%
70.27%
66.53%
67.21%
66.31%
65.41%
67.97%
68.42%
67.72%
67.65%
66.40%
Operating Margin %
52.84%
51.02%
44.65%
21.42%
21.18%
20.55%
21.31%
25.49%
26.83%
26.30%
24.47%
18.86%
NOPAT Margin %
36.59%
35.75%
30.70%
14.56%
21.21%
17.62%
17.67%
24.01%
23.42%
22.17%
18.35%
12.99%
Net Margin %
35.71%
36.24%
31.01%
13.51%
19.62%
13.46%
31.04%
15.08%
24.61%
25.10%
25.11%
14.95%
Tax Rate %
30.74%
29.94%
31.26%
32.04%
-0.16%
14.23%
17.07%
5.80%
12.70%
15.71%
25.00%
31.14%
ROA
16.00%
14.27%
12.73%
5.26%
8.56%
6.68%
6.44%
9.88%
11.28%
9.55%
5.90%
4.07%
ROE
17.07%
15.05%
13.81%
8.63%
12.64%
10.80%
9.45%
14.23%
15.22%
12.81%
8.11%
5.50%
ROIC
37.84%
35.56%
22.92%
6.31%
9.86%
7.48%
7.62%
11.32%
13.32%
11.85%
7.32%
5.02%
Asset Turnover
0.44
0.40
0.41
0.36
0.40
0.38
0.36
0.41
0.48
0.43
0.32
0.31
Inventory Turnover
2.06
2.28
2.74
3.13
2.46
2.64
2.48
2.55
2.47
2.14
1.59
1.60
Equity Multiplier
1.07
1.05
1.08
1.26
1.28
1.64
1.48
1.62
1.47
1.44
1.35
1.34
1.38
1.35
Current Ratio
9.69
12.76
17.79
6.24
4.69
2.57
5.01
4.05
4.88
3.35
3.44
4.84
4.04
4.08
Quick Ratio
8.52
11.57
15.58
4.55
3.49
2.03
3.80
2.98
3.69
2.48
2.51
3.29
2.65
2.49
Debt/Equity Ratio
0.09
0.10
0.36
0.31
0.43
0.26
0.22
0.15
0.18
0.20
0.19
Interest Coverage Ratio
35.41
12.98
Working Capital/Sales
0.25
0.25
0.28
0.24
0.30
0.30
0.30
0.25
0.27
0.35
0.42
0.43
R&D/Sales
0.09
0.09
0.09
0.10
0.09
0.09
0.09
0.08
0.08
0.08
0.08
0.09
Dividend Payout Ratio %
35.63%
39.15%
41.34%
57.75%
35.17%
38.43%
37.46%
22.20%
19.38%
19.96%
24.58%
34.12%
Total Payout
$64.62
45.28
45.39
-20.93
29.11
-209.93
33.30
-140.68
176.53
43.21
219.48
-53.97
-72.38
53.23
173.54%Payout Ratio %
56.13%
40.79%
41.34%
-256.18%
24.42%
-111.80%
135.22%
19.33%
84.77%
-21.42%
-47.21%
48.05%